Maximilian Richter

发表

Enhancing the Stabilization Potential of Lyophilization for Extracellular Vesicles

M. Koch, W. Friess, G. Fuhrmann, 2021, Advanced healthcare materials.

A New Human DSG2-Transgenic Mouse Model for Studying the Tropism and Pathology of Human Adenoviruses

H. Cao, Hongjie Wang, A. Hemminki, 2012, Journal of Virology.

Efficient genome editing in hematopoietic stem cells with helper-dependent Ad5/35 vectors expressing site-specific endonucleases under microRNA regulation

P. Gregory, M. Holmes, Kamola Saydaminova, 2015, Molecular therapy. Methods & clinical development.

Approaches to surface engineering of extracellular vesicles.

P. Vader, G. Fuhrmann, Maximilian Richter, 2021, Advanced drug delivery reviews.

Intracellular Signaling and Desmoglein 2 Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1

D. Carter, C. Zubieta, Kamola Saydaminova, 2015, Journal of Virology.

Extracellular vesicles protect glucuronidase model enzymes during freeze-drying

C. Lehr, C. de Rossi, Kathrin Fuhrmann, 2018, Scientific Reports.

In Vivo Hematopoietic Stem Cell Transduction.

T. Papayannopoulou, H. Kiem, A. Lieber, 2017, Hematology/oncology clinics of North America.

Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy

C. Drescher, P. Sova, Kamola Saydaminova, 2017, Journal of Virology.

Cas-CLOVER is a novel high-fidelity nuclease for safe and robust generation of TSCM-enriched allogeneic CAR-T cells

E. Ostertag, Haibin Xi, D. Shedlock, 2022, Molecular therapy. Nucleic acids.

Structural and Functional Studies on the Interaction of Adenovirus Fiber Knobs and Desmoglein 2

J. Gralow, H. Cao, C. Zubieta, 2013, Journal of Virology.

In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors.

Z. Izsvák, W. Uckert, Kamola Saydaminova, 2016, Blood.

Strategies to Increase Drug Penetration in Solid Tumors

C. Yun, R. Strauss, A. Lieber, 2013, Front. Oncol..

Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells

J. Bartek, C. Drescher, Kamola Saydaminova, 2016, Cancer biology & therapy.

COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups

M. Penny, S. Kelly, A. Shattock, 2022, Infectious Diseases and Therapy.

Preclinical safety, pharmacokinetics, pharmacodynamics and biodistribution studies with Ad35K++ protein, a novel rituximab co‐therapeutic in mice and non‐human primates.

D. Carter, Kamola Saydaminova, Hongjie Wang, 2016 .

Preclinical safety, pharmacokinetics, pharmacodynamics, and biodistribution studies with Ad35K++ protein: a novel rituximab cotherapeutic

D. Carter, Kamola Saydaminova, Hongjie Wang, 2016, Molecular therapy. Methods & clinical development.

Epithelial Junction Opener Improves Oncolytic Adenovirus Therapy in Mouse Tumor Models.

D. Carter, Kamola Saydaminova, Hongjie Wang, 2016, Human gene therapy.

Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin

N. Urban, D. Carter, C. Drescher, 2015, Molecular therapy. Methods & clinical development.

Coadministration of Epithelial Junction Opener JO-1 Improves the Efficacy and Safety of Chemotherapeutic Drugs

D. Carter, H. Cao, C. Drescher, 2012, Clinical Cancer Research.

A Combined In Vivo HSC Transduction/Selection Approach Results in Efficient and Stable Gene Expression in Peripheral Blood Cells in Mice

Z. Izsvák, S. Nilsson, Hongjie Wang, 2017, Molecular therapy. Methods & clinical development.

Role of Fiber Shaft Length in Tumor Targeting with Ad5/3 Vectors

Hongjie Wang, A. Lieber, Maximilian Richter, 2022, Genes.

120 P-MUC1C-ALLO1: An allogeneic car-t for multiple solid tumor indications

E. Ostertag, D. Shedlock, Maximilian Richter, 2020, Journal for ImmunoTherapy of Cancer.

Cancer Therapy : Preclinical Coadministration of Epithelial Junction Opener JO-1 Improves theEf fi cacy andSafety ofChemotherapeuticDrugs

D. Carter, H. Cao, C. Drescher, 2012 .

Efficacy and Safety of Chemotherapeutic Drugs Coadministration of Epithelial Junction Opener JO-1 Improves the Updated

D. Carter, H. Cao, C. Drescher, 2012 .

123 P-MUC1C-ALLO1: A fully allogeneic stem cell memory T cell (TSCM) CAR-T therapy with broad potential in solid tumor

E. Ostertag, Yingying Zhao, D. Shedlock, 2021, Journal for ImmunoTherapy of Cancer.

In Vivo Hematopoietic Stem Cell Transduction.

T. Papayannopoulou, H. Kiem, A. Lieber, 2017, Hematology/Oncology Clinics of North America.

Coadministration of Epithelial Junction Opener JO-1 Improves the Efficacy and Safety of Chemotherapeutic Drugs

D. Carter, H. Cao, C. Drescher, 2012, Clinical Cancer Research.

Studies on the Interaction of Tumor-Derived HD5 Alpha Defensins with Adenoviruses and Implications for Oncolytic Adenovirus Therapy

C. Drescher, P. Sova, Kamola Saydaminova, 2017, Journal of Virology.